![Torsten Hoffmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Torsten Hoffmann
Corporate Officer/Principal chez
American Chemical Society
Profil
Torsten Hoffmann is a member of the American Chemical Society and the Swiss Chemical Society.
He was the Managing Director & Chief Scientific Officer at Proteros biostructures GmbH.
He was also the Head-Global Roche Postdoc at Roche Holding AG from 1999 to 2015.
In 2017 to 2018, he was the Chief Operating Officer at Silence Therapeutics Plc.
He was an Associate at The Scripps Research Institute and the Chief Scientific Officer at Oryzon Genomics SA. He was also the Chief Scientific Officer & Executive VP at Zealand Pharma A from 2013 to 2015.
Dr. Hoffmann holds a doctorate degree from the Swiss Federal Institute of Technology.
Currently, he holds positions as a member of the American Chemical Society and the Swiss Chemical Society.
Postes actifs de Torsten Hoffmann
| Sociétés | Poste | Début |
|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Corporate Officer/Principal | - |
Swiss Chemical Society
 Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Anciens postes connus de Torsten Hoffmann
| Sociétés | Poste | Fin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Directeur des opérations | 21/06/2018 |
| ZEALAND PHARMA A/S | Directeur Technique/Scientifique/R&D | 01/01/2015 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2015 |
| ORYZON GENOMICS S.A. | Directeur Technique/Scientifique/R&D | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Torsten Hoffmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Serves as a discovery service business | Health Services |
